These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36110842)

  • 1. An optimized Factor H-Fc fusion protein against multidrug-resistant
    Shaughnessy J; Chabeda A; Tran Y; Zheng B; Nowak N; Steffens C; DeOliveira RB; Gulati S; Lewis LA; Maclean J; Moss JA; Wycoff KL; Ram S
    Front Immunol; 2022; 13():975676. PubMed ID: 36110842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Complement Factor H-Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant
    Shaughnessy J; Tran Y; Zheng B; DeOliveira RB; Gulati S; Song WC; Maclean JM; Wycoff KL; Ram S
    Front Immunol; 2020; 11():583305. PubMed ID: 33193396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Factor H Domains 6 and 7 Fused to IgG1 Fc Are Immunotherapeutic against
    Shaughnessy J; Lewis LA; Zheng B; Carr C; Bass I; Gulati S; DeOliveira RB; Gose S; Reed GW; Botto M; Rice PA; Ram S
    J Immunol; 2018 Nov; 201(9):2700-2709. PubMed ID: 30266769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Factor H-Fc Chimeric Immunotherapeutic Molecule against Neisseria gonorrhoeae.
    Shaughnessy J; Gulati S; Agarwal S; Unemo M; Ohnishi M; Su XH; Monks BG; Visintin A; Madico G; Lewis LA; Golenbock DT; Reed GW; Rice PA; Ram S
    J Immunol; 2016 Feb; 196(4):1732-40. PubMed ID: 26773149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
    Ram S; Shaughnessy J; DeOliveira RB; Lewis LA; Gulati S; Rice PA
    Immunobiology; 2016 Oct; 221(10):1110-23. PubMed ID: 27297292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion.
    Ngampasutadol J; Ram S; Gulati S; Agarwal S; Li C; Visintin A; Monks B; Madico G; Rice PA
    J Immunol; 2008 Mar; 180(5):3426-35. PubMed ID: 18292569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the interaction between sialylated Neisseria gonorrhoeae and factor H.
    Shaughnessy J; Ram S; Bhattacharjee A; Pedrosa J; Tran C; Horvath G; Monks B; Visintin A; Jokiranta TS; Rice PA
    J Biol Chem; 2011 Jun; 286(25):22235-42. PubMed ID: 21531728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin.
    Shaughnessy J; Lewis LA; Jarva H; Ram S
    Infect Immun; 2009 May; 77(5):2094-103. PubMed ID: 19273554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody.
    Gulati S; Beurskens FJ; de Kreuk BJ; Roza M; Zheng B; DeOliveira RB; Shaughnessy J; Nowak NA; Taylor RP; Botto M; He X; Ingalls RR; Woodruff TM; Song WC; Schuurman J; Rice PA; Ram S
    PLoS Biol; 2019 Jun; 17(6):e3000323. PubMed ID: 31216278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion protein comprising factor H domains 6 and 7 and human IgG1 Fc as an antibacterial immunotherapeutic.
    Shaughnessy J; Vu DM; Punjabi R; Serra-Pladevall J; DeOliveira RB; Granoff DM; Ram S
    Clin Vaccine Immunol; 2014 Oct; 21(10):1452-9. PubMed ID: 25143339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
    Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
    J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
    [No Abstract]   [Full Text] [Related]  

  • 12. Gonococcal lipooligosaccharide sialylation: virulence factor and target for novel immunotherapeutics.
    Ram S; Shaughnessy J; de Oliveira RB; Lewis LA; Gulati S; Rice PA
    Pathog Dis; 2017 Jun; 75(4):. PubMed ID: 28460033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.
    Bettoni S; Shaughnessy J; Maziarz K; Ermert D; Gulati S; Zheng B; Mörgelin M; Jacobsson S; Riesbeck K; Unemo M; Ram S; Blom AM
    JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31661468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor H facilitates adherence of Neisseria gonorrhoeae to complement receptor 3 on eukaryotic cells.
    Agarwal S; Ram S; Ngampasutadol J; Gulati S; Zipfel PF; Rice PA
    J Immunol; 2010 Oct; 185(7):4344-53. PubMed ID: 20826755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Gonococcal Neisserial Surface Protein A (NspA) in Serum Resistance and Comparison of Its Factor H Binding Properties with Those of Its Meningococcal Counterpart.
    Lewis LA; Rice PA; Ram S
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510105
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibacterial Fusion Proteins Enhance
    Laabei M; Colineau L; Bettoni S; Maziarz K; Ermert D; Riesbeck K; Ram S; Blom AM
    Front Immunol; 2020; 11():2122. PubMed ID: 32983170
    [No Abstract]   [Full Text] [Related]  

  • 17. Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?
    Ngampasutadol J; Tran C; Gulati S; Blom AM; Jerse EA; Ram S; Rice PA
    Vaccine; 2008 Dec; 26 Suppl 8():I62-6. PubMed ID: 19388167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic DNA Delivery of an Optimized and Engineered Monoclonal Antibody Provides Rapid and Prolonged Protection against Experimental Gonococcal Infection.
    Parzych EM; Gulati S; Zheng B; Bah MA; Elliott STC; Chu JD; Nowak N; Reed GW; Beurskens FJ; Schuurman J; Rice PA; Weiner DB; Ram S
    mBio; 2021 Mar; 12(2):. PubMed ID: 33727348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
    Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
    mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae.
    Ram S; Sharma AK; Simpson SD; Gulati S; McQuillen DP; Pangburn MK; Rice PA
    J Exp Med; 1998 Mar; 187(5):743-52. PubMed ID: 9480984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.